Position in TAK
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,526,448
+$633,740 QoQ
Shares Held
190,413
+2.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Derivatives in TAK
reported options exposure · as of Mar 31, 2021CallValue
$2,848
CallShares
156
PutValue
$4,565
PutShares
250
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $498,843,244 across 54 Drug Manufacturers - Specialty & Generic names. TAK ranks #18 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,049,626 | $124,076,289 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
3,183,971 | $44,097,998 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
62,008 | $36,769,503 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
647,731 | $31,188,247 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
233,500 | $30,761,290 | |
| 6 | VTRS |
Viatris Inc
|
2,095,093 | $28,304,706 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,111,137 | $26,589,508 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
877,568 | $26,432,348 |
All Filings in TAK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,526,448 | 190,413 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,892,708 | 185,549 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $163,880 | 11,194 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $183,123 | 11,845 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,052 | 676 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,628,963 | 500,677 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $45,788 | 3,220 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $8,074 | 624 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $9,889 | 712 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $10,160 | 712 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $12,298 | 795 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $43,689 | 2,781 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $33,322 | 2,022 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,976 | 960 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,451 | 960 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $52,846 | 3,764 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,351,478 | 94,377 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $3,721,017 | 273,002 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $704,733 | 43,024 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $709,148 | 42,136 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $4,709,071 | 257,890 | Shares | Defined | 2021-05-07 | |
| 2021-03-31 | $4,565 | 250 | Put | Defined | 2021-05-07 | |
| 2021-03-31 | $2,848 | 156 | Call | Defined | 2021-05-07 | |
| 2020-12-31 | $6,058,598 | 332,890 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $5,552,022 | 311,212 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $6,121,212 | 341,395 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $5,052,754 | 332,856 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||